Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
7.19
+0.19 (2.71%)
Oct 9, 2025, 11:45 AM EDT - Market open
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $535.76 million as of October 9, 2025. Its market cap has increased by 57.44% in one year.
Market Cap
535.76M
Enterprise Value
443.80M
1-Year Change
57.44%
Ranking
Category
Stock Price
$7.19
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $535.76M, an increase of 84.24%. That is a compound annual growth rate of 6.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 521.60M | 51.72% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.25B |
| Johnson & Johnson | 456.65B |
| AbbVie | 410.55B |
| UnitedHealth Group | 335.29B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.83B |